Funding for this research was provided by:
Philipps-Universität Marburg
Article History
Received: 20 March 2025
Revised: 6 May 2025
Accepted: 7 May 2025
First Online: 26 May 2025
Declarations
:
: C.B.: received lecturing honoraria and consulting fees from Novartis, Bayer and Portola - all unrelated to this publication. H.H.K.: received travel grants from Alexion and Grifols, lecturing honoraria and consulting fees from Sanofi, Alexion, Roche Pharma, Argenx, UCB and Amgen and research support from Roche and Argenx - all unrelated to this publication. M.D.: was supported by the Deutsche Stiftung Neurologie (DSN, German Foundation of Neurology, project 80721017) and by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany’s Excellence Strategy (Munich Cluster for Systems Neurology: EXC 2145 SyNergy).
: The study was approved by the local ethical committee and performed in accordance with the standards of the Declaration of Helsinki.